Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasisMais Alsousli, Harriet Wikman, Benedikt Asey et al.|Acta Neuropathologica Communications|2025Cited by 3
IMMU-16. ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITYCécile L. Maire, Katrin Lamszus, Malte Mohme et al.|Neuro-Oncology|2024Cited by 1
IMMU-01. IMMUNE PHENOTYPING OF BRAIN METASTASIS PATIENTS IDENTIFIES A DISTINCT DEPLETION AND EXHAUSTION PHENOTYPE OF THE CD4 T CELLS IN BLOOD AND BONE MARROWMerle Reetz, Malte Mohme, Alice Ryba et al.|Neuro-Oncology|2023Cited by 0
NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profileMais Alsousli, Harriet Wikman, Cécile L. Maire et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0